Glycated Haemoglobin (HbA1c) Testing Market to Witness 8.8% Annual Growth

Published: August 2014

Roots Analysis has announced the addition of “Glycated Haemoglobin (HbA1c) Testing Market, 2014 - 2024” report to its portfolio.  The report provides an extensive study of the growing market for HbA1c tests. Amongst other things, the report identifies HbA1c analyzers that are currently available for the point of care and laboratory testing. It also provides a competitive landscape wherein the most efficient Point of Care (POC) devices, based on parameters such as user friendliness and technical details, have been identified. The focus of this report is also to understand the high level trends which are likely to govern the evolution of this market in the US, EU5 and BRICS countries.

Raghav Goyal, the lead analyst, said, “The adoption of HbA1c tests has gradually risen in the recent past. While the laboratory analyzers are likely to strengthen their existing position, a significant growth will also be driven by POC devices. These devices provide instantaneous results and bring a change in overall diabetes management. There are currently 31 POC analyzers in the market; the number is likely to increase in the coming years driving the market forward”.

The research covers detailed profiles and assesses product portfolio of many companies. Examples include:

  • Abbott Laboratories
  • Alere
  • Bio-Rad Laboratories
  • ELITech
  • Eurolyser
  • Roche
  • ROHM
  • Siemens
  • Trinity Biotech

Goyal also stated, “With an increase in worldwide diabetes population, HbA1c test is likely to benefit as it has shown higher accuracy compared to other glucose monitoring assays.I'd like to add that majority of our work is supported by detailed research. For the purposes of this report, we identified 41 companies active in the HbA1c monitoring market. Except for the bigger companies which account for 41% of the overall industry, the nature of the market is quite fragmented. The overall market, in addition to an already well-established macro environment, will continue to benefit from continuous improvements in technology. In our base case, we expect the global HbA1c testing market to witness an annualized growth rate of 8.8%”


Who will benefit from this report?

The research is targeted towards big and small pharma companies working in the field of HbA1c testing. In particular, you will benefit if you are an:

  • Investor
  • CXO level decision maker
  • R&D Manager
  • Business Intelligence / Scientific Analyst
  • Licensing / Portfolio Manager
  • Strategy Manager

For additional details, please visit


About Roots Analysis

Roots Analysis is a specialist market research company, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like us to help you with your growing business needs, get in touch at


  • We are your partners with no equity

  • We fit in your budget

  • We love what we do

  • Chance to prove ourselves

  • Best in class quality of work

  • Most trusted consulting partner in the industry